In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- <i>β</i> Using Electromagnetic Waves

The amyloid- beta (Aβ) protein is a peptide that plays a central role in the development and progression of Alzheimer's disease, originating from the cleavage of the amyloid precursor protein (APP). The peptide's structural variability is linked to different stages and manifestations of Alzheimer's pathology, making it a critical focus for understanding the disease. Current therapeutic strategies primarily involve pharmacological interventions, but they have met with limited success in altering the course of the disease. Our research introduces an innovative approach to address this challenge by employing electromagnetic waves, specifically at a frequency of 900 MHz We performed comprehensive electromagnetic simulations to explore the effects of this frequency on Aβ structures, aiming to offer an alternative non-invasive treatment avenue. Following these electromagnetic simulations, molecular dynamics (MD) simulations were carried out using the Large Scale Atomic/Molecular Massively Parallel Simulation (LAMMPS) software to further investigate the peptide’s response at the atomic and molecular level. These simulations provided insights into the structural dynamics of Aβ under electromagnetic influence, enabling a deeper understanding of the peptide’s behavior. To substantiate the findings from our simulations and the theoretical framework, we conducted a Thioflavin T (ThT) assay and western blot analysis on in vitro Aβ fibril samples which are treated with electromagnetic (EM) wave exposure using a TEM cell device. After 3 hours of EM wave exposure, a noticeable decrease in Aβ fibrils was observed. This experimental validation was essential in confirming the simulation results and reinforcing the theoretical basis of our approach. Together, simulations and experimental evidence provide a strong foundation for exploring electromagnetic-based treatments as a potential therapeutic intervention for Alzheimer’s disease.

Authors

Institutions

Publication Details

Journal
IEEE Transactions on Antennas and Propagation
Published
2025-05-16
DOI
https://doi.org/10.1109/tap.2025.3568638
Citations
3
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
3.49
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- β Using Electromagnetic Waves

Seung‐Jun Park, Sohom Bhattacharjee, Jeong‐Yoon Choi, Moon‐Que Lee et al.
3 citations
IEEE Transactions on Antennas and Propagation
Alzheimer's disease research and treatments
3.49
article

In Vitro Treatment of Alzheimer’s Disease by Disintegrating Amyloid- β Using Electromagnetic Waves

Seung‐Jun Park, Sohom Bhattacharjee, Jeong‐Yoon Choi, Moon‐Que Lee, Choon Sik Cho, Ahmad Bilal, MinYoung Kim, Kyu-Ho Shim, Hea Nam Hong, Sang‐Moon Yun, Minhae Cha, Yash Shah, Abdul Hadee, Young Soo Kim, Hae-Been Han, Chaewon Baek
article en
3 citations

Abstract

The amyloid- beta (Aβ) protein is a peptide that plays a central role in the development and progression of Alzheimer's disease, originating from the cleavage of the amyloid precursor protein (APP). The peptide's structural variability is linked to different stages and manifestations of Alzheimer's pathology, making it a critical focus for understanding the disease. Current therapeutic strategies primarily involve pharmacological interventions, but they have met with limited success in altering the course of the disease. Our research introduces an innovative approach to address this challenge by employing electromagnetic waves, specifically at a frequency of 900 MHz We performed comprehensive electromagnetic simulations to explore the effects of this frequency on Aβ structures, aiming to offer an alternative non-invasive treatment avenue. Following these electromagnetic simulations, molecular dynamics (MD) simulations were carried out using the Large Scale Atomic/Molecular Massively Parallel Simulation (LAMMPS) software to further investigate the peptide’s response at the atomic and molecular level. These simulations provided insights into the structural dynamics of Aβ under electromagnetic influence, enabling a deeper understanding of the peptide’s behavior. To substantiate the findings from our simulations and the theoretical framework, we conducted a Thioflavin T (ThT) assay and western blot analysis on in vitro Aβ fibril samples which are treated with electromagnetic (EM) wave exposure using a TEM cell device. After 3 hours of EM wave exposure, a noticeable decrease in Aβ fibrils was observed. This experimental validation was essential in confirming the simulation results and reinforcing the theoretical basis of our approach. Together, simulations and experimental evidence provide a strong foundation for exploring electromagnetic-based treatments as a potential therapeutic intervention for Alzheimer’s disease.

IEEE Transactions on Antennas and PropagationVol. 73(9)
University of Seoul (KR), Yonsei University (KR), Korea Aerospace University (KR), CHA University Bundang Medical Center (KR), CHA University (KR)
Openalex Percentile: Top 8%
Alzheimer's disease research and treatments
3.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.